These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16816027)
1. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Cleland CM; Deren S; Fuller CM; Blaney S; McMahon JM; Tortu S; Des Jarlais DC; Vlahov D Health Educ Behav; 2007 Apr; 34(2):390-403. PubMed ID: 16816027 [TBL] [Abstract][Full Text] [Related]
2. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Pouget ER; Deren S; Fuller CM; Blaney S; McMahon JM; Kang SY; Tortu S; Andia JF; Des Jarlais DC; Vlahov D J Acquir Immune Defic Syndr; 2005 Aug; 39(4):471-7. PubMed ID: 16010172 [TBL] [Abstract][Full Text] [Related]
3. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621 [TBL] [Abstract][Full Text] [Related]
4. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program. Tesoriero JM; Battles HB; Klein SJ; Kaufman E; Birkhead GS J Am Pharm Assoc (2003); 2009; 49(3):407-16. PubMed ID: 19443321 [TBL] [Abstract][Full Text] [Related]
5. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418 [TBL] [Abstract][Full Text] [Related]
6. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey. Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814 [TBL] [Abstract][Full Text] [Related]
7. Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP). Battles HB; Rowe KA; Ortega-Peluso C; Klein SJ; Tesoriero JM J Urban Health; 2009 Nov; 86(6):946-50. PubMed ID: 19434499 [TBL] [Abstract][Full Text] [Related]
8. Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source. Quinn B; Chu D; Wenger L; Bluthenthal RN; Kral AH Int J Drug Policy; 2014 Sep; 25(5):905-10. PubMed ID: 24930425 [TBL] [Abstract][Full Text] [Related]
9. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618 [TBL] [Abstract][Full Text] [Related]
10. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Coffin PO; Fuller C; Blaney S; Vadnai L; Miller S; Vlahov D Clin Infect Dis; 2004 Feb; 38(3):438-41. PubMed ID: 14727219 [TBL] [Abstract][Full Text] [Related]
11. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Fuller CM; Galea S; Blaney S; Ompad DC; Deren S; Des Jarlais D; Vlahov D Ethn Dis; 2004; 14(4):589-96. PubMed ID: 15724781 [TBL] [Abstract][Full Text] [Related]
12. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002). Finkelstein R; Tiger R; Greenwald R; Mukherjee R J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S83-7. PubMed ID: 12489622 [TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs. Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181 [TBL] [Abstract][Full Text] [Related]
14. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. Tookes HE; Kral AH; Wenger LD; Cardenas GA; Martinez AN; Sherman RL; Pereyra M; Forrest DW; LaLota M; Metsch LR Drug Alcohol Depend; 2012 Jun; 123(1-3):255-9. PubMed ID: 22209091 [TBL] [Abstract][Full Text] [Related]
15. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690 [TBL] [Abstract][Full Text] [Related]
16. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Lewis BA; Koester SK; Bush TW J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615 [TBL] [Abstract][Full Text] [Related]
17. Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland. Golub ET; Bareta JC; Mehta SH; McCall LD; Vlahov D; Strathdee SA Subst Use Misuse; 2005; 40(12):1751-64. PubMed ID: 16419554 [TBL] [Abstract][Full Text] [Related]
18. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program. Shotsky WJ; Cooper JG; Klein SJ Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507 [No Abstract] [Full Text] [Related]
19. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. Des Jarlais DC; McKnight C; Friedmann P J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S73-6. PubMed ID: 12489620 [TBL] [Abstract][Full Text] [Related]
20. Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users. Coffin PO; Latka MH; Latkin C; Wu Y; Purcell DW; Metsch L; Gomez C; Gourevitch MN; AIDS Behav; 2007 Sep; 11(5):652-62. PubMed ID: 17053854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]